Zhu; Fu-Gang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhu; Fu-Gang.The latest application filed is for "compositions for inhibiting checkpoint gene expression and uses thereof".

Company Profile

0.7.12

Zhu; Fu-Gang - Bedford MA
Zhu; Fu-Gang - Dorchester MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions For Inhibiting Checkpoint Gene Expression And Uses Thereof App 20180044669 - AGRAWAL; Sudhir ; et al.	2018-02-15
Compositions for inhibiting checkpoint gene expression and uses thereof Grant 9,828,601 - Agrawal , et al. November 28, 2	2017-11-28
Toll-like Receptor 9 Antagonist And Methods Of Use Thereof App 20170268006 - Agrawal; Sudhir ; et al.	2017-09-21
Toll-like receptor 9 antagonist and methods of use thereof Grant 9,688,993 - Agrawal , et al. June 27, 2	2017-06-27
Compositions For Inhibiting Nlrp3 Gene Expression And Uses Thereof App 20170145412 - Jiang; Weiwen ; et al.	2017-05-25
Compositions For Inhibiting Dux4 Gene Expression And Uses Thereof App 20170009230 - Agrawal; Sudhir ; et al.	2017-01-12
Compositions For Inhibiting Checkpoint Gene Expression And Uses Thereof App 20160251652 - Agrawal; Sudhir ; et al.	2016-09-01
Toll-like Receptor 9 Antagonist And Methods Of Use Thereof App 20160237437 - Agrawal; Sudhir ; et al.	2016-08-18
Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (IRO) antagonists of TLR7 and TLR9 Grant 8,987,221 - Zhu , et al. March 24, 2	2015-03-24
Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto Grant 8,853,177 - Zhu , et al. October 7, 2	2014-10-07
Potentiation of Autoimmune and Inflammatory Disease Treatments by Immune Regulatory Oligonucleotide (IRO) Antagonists of TLR7 and TLR9 App 20110171209 - Zhu; Fu-Gang ; et al.	2011-07-14
Potent Mucosal Immune Response Induced By Modified Immunomodulatory Oligonucleotides App 20110123540 - Wang; Daqing ; et al.	2011-05-26
Modulation of immunostimulatory properties by small oligonucleotide-based compounds App 20100166805 - Agrawal; Sudhir ; et al.	2010-07-01
Modulation of immunostimulatory properties by small oligonucleotide-based compounds Grant 7,713,535 - Agrawal , et al. May 11, 2	2010-05-11
Use of Inhibitors of Toll-Like Receptors in the Prevention and Treatment of Hypercholesterolemia and Hyperlipidemia and Diseases Related Thereto App 20100098685 - Zhu; Fu-Gang ; et al.	2010-04-22
Potent mucosal immune response induced by modified immunomodulatory oligonucleotides App 20050222072 - Wang, Daqing ; et al.	2005-10-06
Modulation of immunostimulatory properties by small oligonucleotide-based compounds App 20050130918 - Agrawal, Sudhir ; et al.	2005-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.